🇺🇸 FDA
Pipeline program

Matched placebo for test product, Itepekimab

LTS18420

Phase 3 small_molecule active

Quick answer

Matched placebo for test product, Itepekimab for Chronic rhinosinusitis with nasal polyps is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Chronic rhinosinusitis with nasal polyps
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials